Allmed Medical(SZ:002950) Cai Jing Wang·2025-08-26 14:05Core Insights - The company reported a total revenue of 1.676 billion yuan for the first half of 2025, representing a year-on-year increase of 5.99% [1] - The net profit attributable to shareholders reached 199 million yuan, up 6.87% year-on-year [1] - The net profit excluding non-recurring gains and losses was 185 million yuan, reflecting an 8.87% increase compared to the previous year [1] - The net cash flow from operating activities was 345 million yuan, which is a 5.45% increase year-on-year [1] R&D and Innovation - The company adhered to an innovation-driven development strategy, increasing R&D investment to 58.83 million yuan in the first half of 2025, a 51.59% increase from the same period last year [1] - As of July 31, 2025, the company held a total of 74 effective invention patents, 321 utility model patents, 77 design patents, and 22 software copyrights, marking a 12.38% increase compared to the previous year [1] Business Focus - The company is dedicated to the medical health sector, primarily engaged in the R&D, production, and sales of medical consumables, disposable medical devices, infection protection products, and home care products [1] - The core business focuses on medical consumables, with two main product segments: medical devices and consumer products [1]